DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Kristin Peck - 9 Eli Lilly - 2 Jim Cramer - 1 Angela Shippy - 1 Anat Ashkenazi - 1 Svanika Balasubramanian - 1 Bobbie - 1 Laura Modi - 1
Top related locs:
Changemakers Cloudflare
Top related orgs:
CNBC - 2 Global Healthcare - 1 Nonprofit - 1 U.S - 1 RePurpose Global - 1 rePurpose - 1 Women's Soccer League - 1 Dandelion Energy - 1

Search resuls for: "Kristin Peck"


12 mentions found


☆ Zoetis CEO Kristin Peck on Q3: Earnings beat driven by broad portfolio
  + stars: | 2024-11-04 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZoetis CEO Kristin Peck on Q3: Earnings beat driven by broad portfolioKristin Peck, Zoetis CEO, joins 'Money Movers' to discuss Zoetis' quarterly earnings results, what allowed the company to beat earnings expectations, and much more.
Persons: Kristin Peck
☆ Zoetis CEO Kristin Peck sits down with Jim Cramer
  + stars: | 2024-06-28 | by ( Jim Cramer | ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZoetis CEO Kristin Peck sits down with Jim CramerZoetis CEO Kristin Peck joins 'Mad Money' host Jim Cramer to talk the state of pet health care, research and development investments, Avian Flu treatments and more.
Persons: Kristin Peck, Jim Cramer
☆ Zoetis CEO Kristin Peck on Q1 earnings
  + stars: | 2024-05-02 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZoetis CEO Kristin Peck on Q1 earningsZoetis CEO Kristin Peck joins 'Money Movers' to discuss the company's quarterly earnings results, what the growth is attributable to, and what differentiates Zoetis from competitors.
Persons: Kristin Peck
☆ Journey to the Future
  + stars: | 2024-04-19 | by ( Sharon Epperson | ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailJourney to the FutureRecent innovations in health tech are leading to product breakthroughs and improved patient care for humans and animals alike. Zoetis CEO Kristin Peck, and AWS Senior Physician Executive & Clinical Innovation Lead, Global Healthcare and Nonprofit Dr. Angela Shippy are at the forefront. Hear how they are leading through rapid technological advancements, while rooting out bias and ensuring different perspectives are considered when leveraging the power of AI.
Persons: Kristin Peck, Angela Shippy Organizations: Global Healthcare, Nonprofit
☆ CNBC Changemakers: Fortune 500 CEOs, Naomi Osaka and Alex Cooper share a success secret
  + stars: | 2024-02-28 | by ( Julia Boorstin | ) www.cnbc.com   time to read: +5 min
Leading the way are health care, with 22%; tech, with 14%; and consumer products and financial services, tied at 10%. Kate Ryder is closing major gaps in women's and family health care with Maven. Michelle Zatlyn, co-founder and chief operating officer at Cloudflare, is giving companies AI tools to bolster cybersecurity and lower costs for vulnerable, critical infrastructure providers, including schools and local election systems. The Changemakers serve as a reminder that success is a result of leading in ways that are authentic. In the book she explored the concept of "reformers" — women working to fix broken systems.
Persons: Anat Ashkenazi, Eli Lilly, Svanika Balasubramanian, Bobbie, Laura Modi, Baby2Baby, Norah Weinstein, Kelly Sawyer Patricof, Alex Cooper, Tracee Ellis Ross, Naomi Osaka, Balasubramanian, Jessica Chang, Maayan Cohen, Kate Ryder, Maven, Monique Rodriguez, Jessica Berman, Kathy Hannun, Clara Shih, Michelle Zatlyn, Kristin Peck, Julia Boorstin Organizations: CNBC, U.S, RePurpose Global, rePurpose, Women's Soccer League, Dandelion Energy, cybersecurity Locations: Changemakers, Cloudflare
☆ The pet drugs vets are now prescribing look a lot more like human medications
  + stars: | 2024-02-28 | by ( Ian Thomas | ) www.cnbc.com   time to read: +7 min
If you want to understand how different the human and animal medicine and vaccine industries have historically been, you don't need to look much further than weight loss drugs. When Pfizer spun off its animal health business in 2013 creating Zoetis, about 65% of the company's business was livestock-related. That has flipped now, with 64% of the company's revenue coming from products for companion animals like cats and dogs. Peck credits the Pfizer spinoff for allowing Zoetis to better balance what the company wanted to do in animal health versus the human health side. A similar product was approved for cats, marking the first time that monoclonal antibody treatments, which have become increasingly popular for treating human illnesses, have been used to treat pet osteoarthritis pain.
Persons: Kristin Peck, Eli Lilly, Peck, Zoetis, We've, it's, We'll Organizations: CNBC, Novo Nordisk, Pfizer, AstraZeneca, FDA
☆ Zoetis CEO Kristin Peck on Q4 earnings
  + stars: | 2024-02-13 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZoetis CEO Kristin Peck on Q4 earningsKristin Peck, Zoetis CEO, joins 'Money Movers' to discuss what Zoetis' guidance says about Peck's business expectations, factors that are contributing to their growth relative to fundamentals, and how consumers are thinking about their pets.
Persons: Kristin Peck
☆ Zoetis CEO on Q3 earnings: We keep seeing the resilience of the animal health sector amid downturns
  + stars: | 2023-11-02 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZoetis CEO on Q3 earnings: We keep seeing the resilience of the animal health sector amid downturnsKristin Peck, Zoetis CEO, joins 'Squawk on the Street' to discuss her insights into livestock and pet care products, how tied Zoetis' business is to the macro economy, and more.
Persons: Kristin Peck
☆ Zoetis CEO Kristin Peck on Q2 earnings results, state of animal health care
  + stars: | 2023-08-08 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZoetis CEO Kristin Peck on Q2 earnings results, state of animal health careKristin Peck, Zoetis CEO, joins 'Squawk on the Street' to discuss what the company's guidance was largely driven by, the most important aspect of Zoetis' business, and how new GLP-1 drugs could play into Zoetis' business.
Persons: Kristin Peck
☆ Zoetis CEO Kristin Peck on veterinary workforce challenges and recession resilience of pet industry
  + stars: | 2023-01-10 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZoetis CEO Kristin Peck on veterinary workforce challenges and recession resilience of pet industryKristin Peck, CEO of Zoetis, joins 'The Exchange' to discuss the pandemic pet boom, demographic shifts among pet owners, and the labor capacity issues associated with veterinary services.
☆ Watch CNBC's full interview with Zoetis CEO Kristin Peck
  + stars: | 2022-11-03 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's full interview with Zoetis CEO Kristin PeckKristin Peck, Zoetis CEO, joins 'Closing Bell' to discuss Zoetis stocks dropping after a worse than expected earnings report, the supply constraints that has been adding pressure to key growth drivers, and the animal pharmaceutical demand outlook for 2023.
☆ Demand for animal medicine remains fundamentally strong, says Zoetis CEO Kristin Peck
  + stars: | 2022-11-03 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDemand for animal medicine remains fundamentally strong, says Zoetis CEO Kristin PeckZoetis CEO Kristin Peck joins 'Closing Bell' to discuss Zoetis stocks dropping after a worse than expected earnings report, the supply constraints that has been adding pressure to key growth drivers, and the demand outlook for 2023.
0 next >>
Total: 12